Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies

Stem Cell Research

Volumn 5, Issue 2, 2010, Pages 104-119

  Barbaric, Ivana ^a   Gokhale, Paul J ^a   Jones, Mark ^a   Glen, Adam ^a   Baker, Duncan ^b   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PINACIDIL; PROTEIN KINASE; PROTEIN MNK1; PROTEIN MSK1; PROTEIN PRK2; PROTEIN ROCK; PROTEIN RSK1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ANALYSIS; HUMAN; HUMAN CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

EID: 77955843624     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.04.006     Document Type: Article

References (34)

1. Aflatoonian B., Ruban L., Shamsuddin S., Baker D., Andrews P., Moore H. Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev. Biol. Anim. 2010, 46:236-241.
2. Andrews P.W., Banting G., Damjanov I., Arnaud D., Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984, 3:347-361.
3. Arena J.P., Kass R.S. Enhancement of potassium-sensitive current in heart cells by pinacidil. Evidence for modulation of the ATP-sensitive potassium channel. Circ. Res. 1989, 65:436-445.
4. Arrigoni-Martelli E., Nielsen C.K., Olsen U.B., Petersen H.J. N''-Cyano-N-4-pyridyl-N'-1, 2, 2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator. Experientia 1980, 36:445-447.
5. Ashcroft S.J., Ashcroft F.M. Properties and functions of ATP-sensitive K-channels. Cell. Signal. 1990, 2:197-214.
6. Audette M.C., Greenwood S.L., Sibley C.P., Jones C.J., Challis J.R., Matthews S.G., Jones R.L. Dexamethasone stimulates placental system A transport and trophoblast differentiation in term villous explants. Placenta 2010, 31:97-105.
7. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
8. Baker D.E., Harrison N.J., Maltby E., Smith K., Moore H.D., Shaw P.J., Heath P.R., Holden H., Andrews P.W. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 2007, 25:207-215.
9. Blum B., Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 2008, 100:133-158.
10. Buttery L.D., Bourne S., Xynos J.D., Wood H., Hughes F.J., Hughes S.P., Episkopou V., Polak J.M. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 2001, 7:89-99.
11. Chen S., Do J.T., Zhang Q., Yao S., Yan F., Peters E.C., Scholer H.R., Schultz P.G., Ding S. Self-renewal of embryonic stem cells by a small molecule. Proc. Natl Acad. Sci. USA 2006, 103:17266-17271.
12. Cohen P. Protein kinases-the major drug targets of the twenty-first century?. Nat. Rev. Drug Discov. 2002, 1:309-315.
13. Damoiseaux R., Sherman S.P., Alva J.A., Peterson C., Pyle A.D. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 2009, 27:533-542.
14. Desbordes S.C., Placantonakis D.G., Ciro A., Socci N.D., Lee G., Djaballah H., Studer L. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2008, 2:602-612.
15. Draper J.S., Pigott C., Thomson J.A., Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 2002, 200:249-258.
16. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Meisner L., Zwaka T.P., Thomson J.A., Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 2004, 22:53-54.
17. Glauche I., Lorenz R., Hasenclever D., Roeder I. A novel view on stem cell development: analysing the shape of cellular genealogies. Cell Prolif. 2009, 42:248-263.
18. Kawasome H., Papst P., Webb S., Keller G.M., Johnson G.L., Gelfand E.W., Terada N. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl Acad. Sci. USA 1998, 95:5033-5038.
19. Kawasumi M., Nghiem P. Chemical genetics: elucidating biological systems with small-molecule compounds. J. Invest. Dermatol. 2007, 127:1577-1584.
20. Liew C.G., Draper J.S., Walsh J., Moore H., Andrews P.W. Transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007, 25:1521-1528.
21. Lowenberg M., Stahn C., Hommes D.W., Buttgereit F. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 2008, 73:1025-1029.
22. Malhi H., Irani A.N., Rajvanshi P., Suadicani S.O., Spray D.C., McDonald T.V., Gupta S. KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting. J. Biol. Chem. 2000, 275:26050-26057.
23. Okuyama Y., Yamada M., Kondo C., Satoh E., Isomoto S., Shindo T., Horio Y., Kitakaze M., Hori M., Kurachi Y. The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K+channel expressed in a mammalian cell line, HEK293T cells. Pflugers Arch. 1998, 435:595-603.
24. Peerani R., Bauwens C., Kumacheva E., Zandstra P.W. Patterning mouse and human embryonic stem cells using micro-contact printing. Meth. Mol. Biol. 2009, 482:21-33.
25. Petersen H.J., Nielsen C.K., Arrigoni-Martelli E. Synthesis and hypotensive activity of N-alkyl-N''-cyano-N'-pyridylguanidines. J. Med. Chem. 1978, 21:773-781.
26. Ringler G.E., Kallen C.B., Strauss J.F. Regulation of human trophoblast function by glucocorticoids: dexamethasone promotes increased secretion of chorionic gonadotropin. Endocrinology 1989, 124:1625-1631.
27. Schuldiner M., Yanuka O., Itskovitz-Eldor J., Melton D.A., Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 2000, 97:11307-11312.
28. Skeen J.E., Bhaskar P.T., Chen C.C., Chen W.S., Peng X.D., Nogueira V., Hahn-Windgassen A., Kiyokawa H., Hay N. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 2006, 10:269-280.
29. Sun M., Wang G., Paciga J.E., Feldman R.I., Yuan Z., Ma X., Shelley S.A., Jove R., Tsichlis P.N., Nicosia S.V., Cheng J.Q. AKT1/PKB kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 2001, 159:431-437.
30. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
31. Watanabe S., Umehara H., Murayama K., Okab M., Kimura T., Nakano T. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 2006, 25:2697-2707.
32. Watanabe K., Ueno M., Kamiya D., Nishiyama A., Matsumura M., Wataya T., Takahashi J.B., Nishikawa S., Nishikawa S., Muguruma K., Sasai Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25:681-686.
33. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.
34. Zhu S., Wurdak H., Wang J., Lyssiotis C.A., Peters E.C., Cho C.Y., Wu X., Schultz P.G. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 2009, 4:416-426.